Study uses MRI and blood clues after ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks for biological and imaging markers that may predict heart/vascular outcomes after an ischemic stroke. You may join if you are eligible for standard stroke treatment and can complete planned follow-up and MRI scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have an ischemic stroke confirmed on MRI
- Have a blockage in a main artery in the brain (M1 and/or M2)
- Be eligible for thrombolysis and/or thrombectomy (standard stroke treatments)
- Be able to give consent (or have next of kin consent) and complete follow-up at 3 months at Pierre Wertheimer Hospital in Lyon
- Have a social security number
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults who have had an ischemic stroke confirmed on MRI and a blockage in a major brain artery. Researchers want to understand stroke care in people who can receive standard clot-busting treatment (thrombolysis) and/or clot removal (thrombectomy).
This study follows patients who come to the hospital with a brain blood vessel emergency, such as a stroke. Researchers want to learn more about these conditions and how patients do over time, which may help improve care for others in the future. You would not receive any new treatment, but your health information would be tracked.
This study looks at inflammation-related changes soon after an acute ischemic stroke (a type caused by a blocked blood vessel). It may help researchers understand what factors drive recovery and how they could be targeted in the future.
This study looks at how the brain's connections change after a stroke and its treatment. It uses MRI scans to understand recovery and may help improve future stroke care.
This study looks at how certain proteins in the blood change after a procedure to remove a large blockage in a brain artery. The goal is to better understand recovery after stroke treatment.
This trial looks at blood “inflammation-related” biomarkers to understand what happens early after certain sudden brain events. It may help doctors predict outcomes and tailor treatment for people like those with stroke types that sometimes need a clot-removal procedure.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.